Promising results have been obtained using brachytherapy in the treatm
ent of brain turners. Very low-dose rate brachytherapy (60-100 Gy give
n at 0.05-0.10 Gy/h) has been used for low-grade gliomas, resulting in
5- and 10-year survival probabilities of 85% and 83% for pilocytic as
trocytomas and 61% and 51% for grade II astrocytomas. Only 2.6% of pat
ients had symptomatic radiation necrosis. For faster-growing high-grad
e gliomas, temporary im plants delivering about 60 Gy at 0.30-0.60 Gy/
h are generally used. The largest series have reported median survival
times of 12-13 months after brachytherapy for recurrent malignant gli
omas and 18-19 months after diagnosis of primary glioblastomas treated
with external beam radiotherapy and brachytherapy boost. A recent pro
spective, randomized trial demon strated significantly improved surviv
al for high-grade glioma patients who had brachytherapy boost. However
, over 50% of patients who undergo brachytherapy for malignant gliomas
require reoperation for tumor progression and/or radiation necrosis.
Strategies are under development to improve local control without incr
easing radiation toxicity. (C) 1997 Wiley-Liss, Inc.